Novo Nordisk A/S stock price
NVO
#63

40,75 $
  

3.64%

Novo Nordisk A/S Info

Capitalización de mercado
180,72B $

3.64%

Volumen diario
589,06M $
Tipo de activo
Acciones
Empleados
78387
Fundado
Dec 21, 1923
Exchange principal
New York Stock Exchange
Número CIK
0000353278

Datos de acciones tokenizadas

Prom. del precio tokenizado
40,47 $
Diferencia de precio
+0,2831 $(-0.69%)
Capitalización de mercado tokenizada
3,26M $

2.29%

Volumen tokenizado (24h)
856,95K $

6.75%

Emisores
Contratos
Exploradores
Convertidor de NVO a USD
NVO
USD
Rendimiento de precios
Baja
39,1 $
Alta
40,73 $

Cargando datos

Por favor, espera, estamos cargando datos de gráficos

Novo Nordisk A/S comunidad

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Datos de Precio en vivo

The current price of Novo Nordisk A/S in the market is 40,75 $, with a 24-hour trading volume of 589,06M $. The asset's market cap is 180,72B $, after moving 3.65% in the last day.

Tokenized Novo Nordisk A/S is trading at 40,47 $, with a tokenized market cap of 3,26M $ and a 24-hour trading volume of 856,95K $. The tokenized asset has moved 2.30% in the past 24 hours.